PRECISESADS http://www.precisesads.eu/, an IMI funded project, has now recruited over 2 000 people into its pan-European clinical study on systemic autoimmune diseases such as rheumatoid arthritis and lupus. This milestone means that the project is well on track towards its final goal of recruiting a total of 2 500 people from across 9 different countries.
Within the project, patients with systemic autoimmune diseases and healthy people are providing blood and urine samples to undergo detailed molecular analysis at several collaborating laboratories. ‘This will allow us to gain a full molecular profile of the patients and (hopefully) allow us to cluster the patients into groups based on their molecular profile instead of their clinical symptoms,’ explains project coordinator Marta Alarcón-Riquelme of GENYO in Spain. ‘This will then allow clinicians to tailor the therapies to the specific pathways to be targeted in a sort of personalised medicine.’
Leave a reply →